FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
AZoLifeSciences on MSN1h
Why 3D Tumoroid Models Are the Future of Cancer Research
D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...
WBUR2h
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...
Taiwan News3h
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will host a virtual investor event and conference ...
Generative AI In Life Sciences Market Boosts Around USD 1,140.5 Million By 2033, CAGR At 20.35%
Regional Analysis: North America holds 40% of the Generative AI Life Sciences market... Lawrence John Prudour +91 91308 55334 ...